Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
0 hedge funds and large institutions have $0 invested in Orgenesis Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 11 closing their positions.
3.18% less ownership
Funds ownership: 3.18% → 0% (-3.2%)
100% less funds holding
Funds holding: 11 → 0 (-11)
100% less capital invested
Capital invested by funds: $675K → $0 (-$675K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 11
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$406K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$170K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$44.6K |
| 4 |
BlackRock
New York
|
-$26.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$21.2K |
ORGS Hedge Fund Activity: Q4 2024 in Review
0 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q4 2024, worth a combined $0 — down 100% from $675K a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of ORGS and 0 opened new positions — a net loss of 11 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Vanguard Group, exiting entirely with an estimated $406K sold.
- 0 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q4 2024, down from 11 in Q3 2024.
- Funds reported $0 of Orgenesis Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
- 0 funds opened new Orgenesis Inc. Common Stock positions in Q4 2024 and 11 closed out, a net change of -11 holders.
- The largest Orgenesis Inc. Common Stock seller in Q4 2024 was Vanguard Group, an estimated $406K sold.
Based on aggregated 13F filings for Q4 2024.